SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
NCT05198674
Recruiting
The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in subjects treated with renal denervation. Additionally, long-term follow-up data will also be collected from eligible subjects previously treated in the SPYRAL PIVOTAL-SPYRAL HTN-OFF MED and SPYRAL HTN-ON MED studies.
Gender:
All
Ages:
18 years and above
Locations: Piedmont Heart Institute, Atlanta, Georgia +26 locations
Conditions: Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
Register for Updates
Oral Anti Diabetic Agents in the Hospital
NCT04416269
Recruiting
This randomized controlled clinical trial will assess whether continuation of home oral antidiabetic agents during hospitalization can be used as a safe and effective alternative to insulin therapy in the management of diabetes in the hospital. The primary outcome of the study is to determine differences in glycemic control as measured by mean daily blood glucose concentration between oral antidiabetic medications and basal bolus therapy in hospitalized patients with type 2 diabetes (T2D).
Gender:
All
Ages:
Between 18 years and 80 years
Locations: Emory University Hospital Midtown, Atlanta, Georgia +2 locations
Conditions: Diabetes Mellitus
Register for Updates
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
NCT03012529
Recruiting
The purpose of this research study is to determine if rifampin, an antibiotic (a medicine that treats infections), is effective in treating osteomyelitis (infection of the bone) of the foot in diabetic patients. Despite use of powerful antibiotics prescribed over a long period of time, many diabetic patients remain at a high risk for needing an amputation of part of the foot or lower leg because the osteomyelitis is not cured. Some small research studies have shown that addition of rifampin to o... Read More
Gender:
All
Ages:
Between 18 years and 89 years
Locations: Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia +29 locations
Conditions: Osteomyelitis, Diabetes, Amputation
Register for Updates
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
NCT04527107
Recruiting
Part A of the study is conducted to select the THR-149 dose level. Part B of the study is conducted to assess the efficacy and safety of the selected dose level compared to aflibercept, up to Month 3. As from Month 3, in about half of the subjects, the effect of a single flip-over injection (aflibercept or THR-149) will be evaluated when administered 1 month after the 3 monthly injections of THR-149 or aflibercept. In the other subjects, the durability of 3 monthly injections of THR 149 or afli... Read More
Gender:
All
Ages:
18 years and above
Locations: Southeast Retina Center, Augusta, Georgia +79 locations
Conditions: Diabetes Mellitus, Diabetic Retinopathy, Diabetic Macular Edema
Register for Updates
Eversense® Non-adjunctive Use Post Approval Study
NCT04836546
Recruiting
This is a non-blinded, prospective, multi-center, single arm longitudinal cohort study (patient serving as their own control), to evaluate the effectiveness of diabetes with the Eversense CGM System non-adjunctively compared to self-monitoring of blood glucose (SMBG) using a blood glucose (BG) meter in participants with either Type 1 or Type 2 diabetes. Subjects will serve as their own control, with their baseline based on using SMBG to manage their diabetes for the first 6 months followed by us... Read More
Gender:
All
Ages:
18 years and above
Locations: Atlanta Diabetes Associates, Atlanta, Georgia +15 locations
Conditions: Diabetes
Register for Updates
Continuous Monitoring and Control of Hypoglycemia
NCT03340831
Recruiting
Evaluate safety of non-adjunctive CGM use in CGM naive participants.
Gender:
All
Ages:
2 years and above
Locations: Atlanta Diabetes, Atlanta, Georgia +24 locations
Conditions: Diabetes
Register for Updates
Dexcom CGM in Long-term Care
NCT04818242
Recruiting
Diabetes is prevalent in adults admitted to subacute rehab (SAR) and long-term care (LTC) skilled nursing care facilities. Management of diabetes in these facilities is challenging due to number of older adults with higher prevalence of other diseases, functional disability, and altered nutritional intake, which increase the risk of hypoglycemia (low blood sugars). The investigators propose to conduct this randomized controlled trial to determine whether the use of Dexcom CGM with Glucose Teleme... Read More
Gender:
All
Ages:
18 years and above
Locations: A.G. Rhodes, Atlanta, Georgia +1 locations
Conditions: Diabetes, Diabetes Mellitus, Type 2
Register for Updates
Dexcom G6 Intervention Study
NCT03877068
Recruiting
The study will assess if Continuous Glucose Monitoring (CGM) represents a better tool to guide healthcare providers in adjusting insulin therapy, by providing a more complete 24-hour assessment of glucose values compared to Point of Care (POC) testing, during hospitalization and after hospital discharge in general medicine and surgery patients with T2D and T1D
Gender:
All
Ages:
18 years and above
Locations: Emory University Hospital, Atlanta, Georgia +2 locations
Conditions: Diabetes Mellitus
Register for Updates
Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)
NCT01972113
Recruiting
The undercarboxylated fractions of the two vitamin K-dependent proteins osteocalcin and matrix Gla protein have been shown to play key roles in type 2 diabetes and cardiovascular disease (at least in mouse models). Clinical trials are needed to isolate the effects of vitamin K manipulation on carboxylation of these two proteins (osteocalcin and matrix GLA protein) and their subsequent effects on markers of diabetes and cardiovascular disease risk. The purpose of this pilot randomized, double-bli... Read More
Gender:
All
Ages:
Between 8 years and 17 years
Locations: Medical College of Georgia; Augusta University, Augusta, Georgia
Conditions: Obesity, Insulin Resistance, Insulin Sensitivity, Prediabetes, Dyslipidemia, Diabetes
Register for Updates